Organogenesis Holdings Inc. Financial Ratios
ORGO|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
1.9%
Profit Margin
1.1%
Net Income / Revenue
Asset Turnover
0.72
Revenue / Total Assets
Equity Multiplier
2.28
Total Assets / Equity
Composite: 1.9% (reported: 1.9%)
Profitability
Liquidity
Current Ratio
3.62
Quick Ratio
3.32
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.72
Inventory Turnover
-
Days Sales Outstanding
183 days
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
-4.7%
-2.9pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.